
Publikationen von Johannes Kopf-Beck
Alle Typen
Zeitschriftenartikel (18)
1.
Zeitschriftenartikel
123, S. 353 - 369 (2025)
Dissecting depression symptoms: Multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulation. BRAIN BEHAVIOR AND IMMUNITY 2.
Zeitschriftenartikel
192, 104801 (2025)
The role of concreteness in repetitive negative thinking: Temporal dynamics and the predictive value for depression throughout psychological treatment. Behaviour research and therapy 3.
Zeitschriftenartikel
93 (1), S. 24 - 35 (2024)
Effectiveness of Schema Therapy versus Cognitive Behavioral Therapy versus Supportive Therapy for Depression in Inpatient and Day Clinic Settings: A Randomized Clinical Trial. PSYCHOTHERAPY AND PSYCHOSOMATICS 4.
Zeitschriftenartikel
2024, 9191823 (2024)
Ecological Momentary Assessment versus Weekly Questionnaire Assessment of Change in Depression. DEPRESSION AND ANXIETY 5.
Zeitschriftenartikel
14, 1160075 (2023)
Developing a mechanism-based therapy for acute psychiatric inpatients with psychotic symptoms: an Intervention Mapping approach. FRONTIERS IN PSYCHIATRY 6.
Zeitschriftenartikel
Targeting metacognitive change mechanisms in acute inpatients with psychotic symptoms: feasibility and acceptability of a modularized group intervention. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)
7.
Zeitschriftenartikel
Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders. NEUROPSYCHOPHARMACOLOGY (2023)
8.
Zeitschriftenartikel
Evaluating the role of maladaptive personality traits in schema therapy and cognitive behavioural therapy for depression. PSYCHOLOGICAL MEDICINE, PII S0033291722001209 (2022)
9.
Zeitschriftenartikel
Psychometric Properties of the German Version of the Young Positive Schema Questionnaire (YPSQ) in the General Population and Psychiatric Patients. JOURNAL OF PERSONALITY ASSESSMENT, S. 1 - 10 (2021)
10.
Zeitschriftenartikel
Separating EEG correlates of stress: Cognitive effort, time pressure, and social-evaluative threat. EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
11.
Zeitschriftenartikel
160, 107923 (2021)
Imagery of negative interpersonal experiences influence the neural mechanisms of social interaction. NEUROPSYCHOLOGIA 12.
Zeitschriftenartikel
22 (1), 13 (2021)
Adapting the randomised controlled trial (RCT) for precision medicine: introducing the nested-precision RCT (npRCT). TRIALS 13.
Zeitschriftenartikel
271 (3), S. 413 - 415 (2021)
Moving toward a process-oriented perspective in the personalized treatment of depression. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 14.
Zeitschriftenartikel
18 (1), 170 (2020)
Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry. BMC MEDICINE 15.
Zeitschriftenartikel
20 (1), 506 (2020)
Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT. BMC PSYCHIATRY 16.
Zeitschriftenartikel
7 (1), S. 423 - 447 (2019)
The Meaning of Being German: An Inductive Approach to National Identity. JOURNAL OF SOCIAL AND POLITICAL PSYCHOLOGY 17.
Zeitschriftenartikel
29, S. S16 - S16 (2019)
Deciphering polygenic risk for inflammation and depressive symptoms: a network analysis approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY 18.
Zeitschriftenartikel
268 (3), S. 215 - 217 (2018)
Translational research as prerequisite for personalized psychiatry. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE Meeting Abstract (2)
19.
Meeting Abstract
31. 26th Conference of the European-Sleep-Research-Society (ESRS), Athens, GREECE, 27. September 2022 - 30. September 2022. (2022)
Relationship between sleep-wake behaviour, light and depression status of inward-patients over 7 weeks. In JOURNAL OF SLEEP RESEARCH, 20.
Meeting Abstract
29, S. S681 - S681. ECNP Workshop on Early Career Scientists in Europe, Nice, FRANCE, 07. März 2019 - 10. März 2019. (2019)
Deciphering polygenic risk for inflammation and depressive symptoms: A two-sample network analysis approach. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,